A second-generation anti-CD40L monoclonal antibody has shown remarkable efficacy in reducing multiple sclerosis (MS) disease activity, according to new trial data. This treatment nearly eliminated new brain lesions on MRI scans at 48 weeks for patients receiving the highest dose, without increasing the risk of infections or thrombotic events.
Extreme temperatures are linked to increased stroke mortality, disproportionately affecting low-income regions, according to a new multinational study involving nearly 6 million strokes. The research revealed that out of every 1000 ischemic or hemorrhagic stroke deaths, around 11 were due to extreme hot and cold days.
Previous research has shown that regular caffeine intake is associated with a reduced risk of developing Parkinson's disease. However, the effects of caffeine on disease progression in patients already diagnosed with Parkinson's have not been extensively studied.
Alzheimer's disease is characterized by the accumulation of amyloid plaques in the brain, a hallmark that has been notoriously difficult to address. In a groundbreaking study, researchers have focused on manipulating the plexin-B1 protein to enhance the brain's ability to clear these plaques, offering new hope in the fight against this debilitating...
Sleep apnea events during REM sleep are linked to verbal memory impairment in older adults at risk for Alzheimer's disease. A new research highlights the importance of focusing on sleep-stage-specific apnea severity for accurate diagnosis and treatment.
Identifying people with Parkinson's disease (PD) in its prodromal phase has become a priority to open a window for disease-modifying therapies.
Next May 22nd will take place the Multiple Sclerosis Day for relatives and patients. The meeting will take place at the Menador Espai Cultural at 17h (Plaça de l'Hort dels Corders, 4, 12001 Castelló de la Plana, Castelló).
Cognitive impairment, affecting memory, concentration, learning, and decision-making, is prevalent among older adults, with around two-thirds experiencing some level of impairment after the age of 70. Ethnicity plays a role in cognitive dysfunction, with Black individuals at a higher risk compared to White individuals, along with other factors like...
A recent study conducted by UCLA Health suggests that a simple blood test could serve as an effective tool for determining an individual's susceptibility to stroke and cognitive decline later in life. Published in the journal Stroke, the study focused on measuring concentrations of inflammatory molecules in the blood to calculate a risk score for...
A recent study published in Neurology® Clinical Practice suggests a potential association between acid-reducing drugs and heightened risks of migraine and severe headaches.
